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Surface modification of 
microparticles causes differential 
uptake responses in normal  
and tumoral human breast 
epithelial cells
Tania Patiño, Jorge Soriano, Lleonard Barrios, Elena Ibáñez & Carme Nogués
The use of micro- and nanodevices as multifunctional systems for biomedical applications has 
experienced an exponential growth during the past decades. Although a large number of studies 
have focused on the design and fabrication of new micro- and nanosystems capable of developing 
multiple functions, a deeper understanding of their interaction with cells is required. In the present 
study, we evaluated the effect of different microparticle surfaces on their interaction with normal 
and tumoral human breast epithelial cell lines. For this, AlexaFluor488 IgG functionalized polystyrene 
microparticles (3 μm) were coated with Polyethyleneimine (PEI) at two different molecular weights, 
25 and 750 kDa. The effect of microparticle surface properties on cytotoxicity, cellular uptake 
and endocytic pathways were assessed for both normal and tumoral cell lines. Results showed a 
differential response between the two cell lines regarding uptake efficiency and mechanisms of 
endocytosis, highlighting the potential role of microparticle surface tunning for specific cell targeting.
In recent years, the development of micro- and nanotechnology for biomedical applications has attracted 
a great deal of attention. This is due to the unique and controllable physicochemical properties of micro- 
and nanoparticles, which allow them to integrate multiple functions such as biosensing1–4, targeting5–8 
and drug delivery9–11. Recently, a wide range of studies has focused on the fabrication and characteriza-
tion of new micro- and nanoparticles for biomedical purposes. However, a deeper understanding of their 
interactions with biological systems at the cellular level is required for the design of new multifunctional 
micro and nanosystems with potentiated effects on target cells and diminished side effects on healthy 
ones.
Different studies have revealed that size12–15, shape16,17 and surface functionalization of particles18 are 
key factors regarding their internalization by cells. Particularly, surface charge of micro- and nanoparti-
cles has been described to play a critical role in their internalization by cells, the cationic particles being 
more efficiently internalized than the anionic ones19,20, in the majority of cases. Thus, with the aim to 
obtain cationic particles, several approaches have been performed, including their coating with cationic 
lipids or polymers. Specifically, particle coating with Polyethyleneimine (PEI) has been of particular rel-
evance21–23 due to the widely known protonsponge effect, which involves the protonation of PEI amine 
groups that leads to endo/lysosomal pH buffering, membrane disruption, and ultimate liberation of 
the content to the cytosol24. Moreover, the proton sponge effect has been shown to be more efficiently 
achieved when a high molecular weight of PEI is used25.
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On the other hand, micro- and nanoparticles cellular uptake and the mechanism of internalization 
can differ among cell types12,13,18,26. This, however, has received less attention in the literature.
Specific antibodies or peptides against certain cell surface markers are used to enhance particle inter-
nalization in target cells27–30. However, other intrinsic properties of non-targeted particles can also have 
a differential effect upon different cell lines18. Moreover, whilst there is a wide range of particle-cell inter-
action studies conducted with nanoparticles, less is known about the interaction of larger particles with 
cells. More research is thus required to improve the strategies for biomedical applications of micron-sized 
delivery systems, as they have been proved to be a good approach for drug delivery31–35.
Hence, the aim of the present work was to provide an integrated study about the impact of different 
non-specific surface modifications of microparticles upon their interaction with different cell types, in 
terms of cytotoxicity, uptake efficiency, mechanism of internalization and intracellular fate. With this 
purpose, 3-μ m polystyrene microparticles were functionalized with a fluorescently-labeled non-specific 
antibody. Then, two types of PEI, both differing on their structure and molecular weight, were used for 
microparticle coating. The cytotoxicity and internalization of those microparticles were studied in two 
human breast epithelial cell lines, one normal and another tumoral.
Results
Effect of 0.05 mM PEI on cell viability. The cytotoxic effect of PEI treatments was evaluated by flow 
cytometry 24 h after incubation of cells with PEI-25 K or PEI-750 K. Figure 1 shows that the percentage of 
viable cells, normalized to the control, was higher than 90% in all cases. Moreover, no significant differ-
ences (P > 0.05) were found between PEI treatments and control cells, indicating that 4 h incubation with 
either PEI-25 K or PEI-750 K 0.05 mM did not cause cytotoxicity in either SKBR-3 or MCF-10A cells.
Characterization of microparticles. Polystyrene microparticles were functionalized with Alexa 
Fluor®488 conjugated goat anti-Rabbit IgG (Alexa488-IgG) and then coated with different molecular 
weight Polyethyleneimine (PEI), 25 kDa or 750 kDa (PEI-25 K or PEI-750 K), as described in Fig.  2a. 
Surface charge of microparticles was evaluated by measuring their ζ -potential (Fig. 2b). Results showed 
that Alexa488-IgG microparticles were successfully coated with PEI, as their negatively charged surface 
changed to positively charged, being significantly higher when PEI-750 K was used. In order to qualita-
tively assess the dispersion status of microparticles, SEM images of microparticles were recorded (Fig. 2c). 
Although the majority of particles were in a monodispersed form, few aggregates were also observed. To 
quantify the amount of monodispersed particles, samples were analyzed using a Flow Cytometer, where 
the amount of fluorescence intensity allowed discriminating between single and aggregated particles 
(Fig.  2d). Figure  2e shows that in all cases the percentage of monodispersed microparticles was above 
80%, which was considered as an acceptable value for our studies.
Microparticle internalization efficiency. Internalization of microparticles by both MCF-10A and 
SKBR-3 cells was measured by flow cytometry. In order to distinguish cells with membrane-attached 
microparticles from cells that had completely internalized them, trypan blue (TB) quenching of extracel-
lular microparticles was performed (optimization of TB concentration to completely quench micropar-
ticle fluorescence is summarized in supplementary data, figures S1 and S2). Figure 3 shows how the TB 
quenching effect was used for distinguishing microparticles internalized from those attached to the cell 
membrane. Fluorescence of Alexa488-IgG-microparticles was analyzed before and after the addition of 
2 mg/ml TB (Fig. 3a). We observed that fluorescence was completely eliminated after TB addition.
Figure  3b shows a schematic representation of the extracellular quenching effect by TB. As TB is 
not capable of penetrating live cells, the quenching effect only occurs in the extracellular space. Thus, 
the fluorescence of microparticles bound to the membrane can be quenched by TB, whereas the inter-
nalized ones remain intact. Figure  3c shows a typical flow cytometry analysis of cells incubated with 
microparticles (in this case MCF-10A cells incubated with PEI-25 K coated microparticles). Two differ-
ent populations of cells were observed before TB addition: the population of cells without microparti-
cles (no fluorescence emission) and the population of cells with microparticles, either internalized or 
bound to the cell membrane (green fluorescence emission). After the addition of TB, the fluorescence of 
Figure 1. Effect of 0.05 mM PEI-25 K or PEI-750 K treatments on the viability of non-tumoral (MCF-
10A) and tumoral (SKBR-3) human breast epitelial cells. 
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non-internalized microparticles was quenched, allowing us to discriminate between microparticles inter-
nalized (green fluorescence) and microparticles adhered to the cell membrane (no fluorescence emis-
sion). Moreover, the addition of TB to the cell suspension permitted to determine cell viability, since TB 
can only enter in cells with damaged plasma membranes. Thus, a third population was observed after the 
TB addition, corresponding to dead cells which emitted red fluorescence due to the presence of TB in 
their cytoplasm. In this study, we used the Q4 population, i.e. live cells with internalized microparticles. 
in order to compare the effect of the different surface modifications of microparticles on their uptake 
efficiency by SKBR-3 and MCF-10A cells.
Figure  4 shows the percentage of live cells with internalized microparticles for both cell lines. We 
observed that MCF-10A cells internalized non-coated microparticles (Alexa488-IgG-microparticles) 
with a 3-fold higher efficiency than SKBR-3 cells. By contrast, PEI coating of microparticles resulted in 
an opposed effect. When PEI coated microparticles (PEI-25 K and PEI-750 K) were used, a significant 
reduction in microparticle internalization was observed in MCF-10A cells, whereas the opposite effect 
Figure 2. Characterization of Alexa488-IgG functionalized microparticles. a) Scheme of Alexa488-
IgG microparticles (non-coated) and coated with different molecular weight PEI (PEI-25 K and PEI-
750 K, respectively). b) ζ -Potential of non-coated and coated (PEI-25 K and PEI-750 K) Alexa488-IgG 
microparticles. c) Representative SEM image of Alexa488-IgG microparticles, in the example coated with 
PEI-25 K. Scale bar corresponds to 20 μ m. Inset shows a magnification of the selected area. d) Representative 
fluorescence intensity histogram of Alexa488-IgG microparticles (in the example coated with PEI-25 K), 
obtained by flow cytometry analysis. e) Percentage of monodisperse, non-coated, PEI-25 K and PEI-750 K 
Alexa488-IgG microparticles, calculated by flow cytometry analyzed as shown in d).
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Figure 3. Quenching effect of Trypan Blue (TP) allowing discriminating internalized microparticles from 
those attached to the cell membrane. a,b) Fluorescence intensity of Alexa488-IgG microparticles before (a) 
and after (b) TB addition, analyzed by flow cytometry. Fluorescence boundary was established with Alexa488-
IgG microparticles fluorescence emission (> 103 a.u.). Inset shows an image of the same Alexa488-IgG 
microparticles before and after TB addition. c,d) Scheme of extracellular quenching effect by TB. After TB 
addition (d), only Alexa488-IgG microparticles attached to the cell membrane can be quenched, TB cannot 
quench internalized ones. e,f) Representative dot-plot of cells incubated with Alexa488-IgG microparticles, 
analyzed by flow cytometry after 4 h of incubation before (e) and after (f) TB addition. In the absence of TB, 
two populations of cells were observed: cells with Alexa488-IgG microparticles (Q4, green), either attached to 
the plasma membrane or internalized, and cells without microparticles (Q3, grey). TB can enter only in cells 
with damaged membrane (dead cells), thus the addition of TB induced the visualization of a new population 
of cells: those emitting in the red cannel (Q1). Therefore, Q3 and Q4 constitute the population of live cells, 
being Q3 cells without microparticles or cells with microparticles attached to the membrane that have been 
quenched, whereas Q4 shows the population of cells that have internalized the microparticles.
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was observed in SKBR-3 cells. In addition, for both cell lines, although a higher percentage of internal-
ization was observed in the case of PEI-750 K, no significant differences were found when compared 
to PEI-25 K. All experiments were conducted by incubating the microparticles in serum-free medium.
Effect of serum and endocytic inhibitors on microparticle internalization. The effect of serum 
and endocytic inhibitors on microparticle internalization was evaluated by flow cytometry, as previously 
Figure 4. Internalization efficiency of non-coated and PEI-coated Alexa488-IgG microparticles by MCF-
10A and SKBR-3 cell lines, analyzed by flow cytometry. Results are representative of three independent 
experiments and data is shown as the mean ± SEM. Different superscripts (a–c) denote groups of 
significance (P < 0.05).
Figure 5. Internalization of Alexa488-IgG functionalized microparticles either coated or not with PEI 
(25K or 750K) by SKBR-3 (a) and MCF-10A (b) cells, when incubated with serum, Cytochalasin D (CD) 
or Dynasore (Dyn). Results are shown as the mean ± SEM. Different superscripts (a–e) denote groups of 
significance (P < 0.05).
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described. Figure  5a,b show the percentages of internalization in SKBR-3 and MCF-10A cells, respec-
tively. For both cell lines, the presence of serum during incubation with microparticles significantly 
reduced their internalization, except in the case of SKBR-3 in presence of non-coated microparticles 
and MCF-10A incubated with PEI-750 K coated microparticles, where internalization was not affected.
Regarding endocytosis inhibition, we observed a cell line dependent effect of macropynocitosis inhi-
bition by cytochalasin D (CD). Whereas in SKBR-3 cells the internalization of all types of microparti-
cles was completely inhibited by CD, in MCF-10A cells the CD effect was only detected in the case of 
non-coated microparticles.
The addition of Dynasore (Dyn) also induced a differential cell response regarding internalization 
of microparticles. In SKBR-3 cells, Dyn did not affect the internalization of any type of microparticles. 
By contrast, the incubation with Dyn significantly reduced the uptake of non-coated microparticles by 
MCF-10A cells. This reduction was not observed in either PEI-25 K or PEI 750 K.
The cytotoxicity of all incubation conditions was determined by the use of TB in flow cytometry 
analyses. Results showed that none of the incubation conditions altered cell survival when compared to 
control cells (figure S3).
Intracellular location of microparticles. In order to determine the intracellular fate of non-coated, 
PEI-25 K and PEI-750 K microparticles in SKBR-3 and MCF-10A cells, immunolocalization of EEA-1 
(endosomal compartment) and LAMP-1 (lysosomal compartment) proteins was carried out. Confocal 
Laser Scanning Microscope (CSLM) analyses showed that at 4 h the majority of microparticles posi-
tively colocalized with LAMP-1 marker, indicating that microparticles were located inside the lysosomal 
compartment (Fig. 6). These results were found for both cell lines and for all microparticle treatments. 
Moreover, 24 h later, the majority of microparticles (> 80%) remained in the lysosomal compartment.
Figure 6. Intracellular location of microparticles, analyzed by Confocal Laser Scanning Microscope 
(CLSM). Orthogonal projections of z-stacks of MCF10A (a,b) or SKBR-3 (c,d) cells incubated with the 
endosome marker EEA1 (red) (a,c) or the lysosome marker LAMP-1(red) (b,d). Microparticles could be 
only observed in lysosomes (orange arrows), but not in endosomes (white arrows). In all cases, cell cortex 
was stained using AlexaFluor® 594-conjugated Phalloidin.
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Discussion
Although the use of micro- and nanosystems for drug delivery has shown a strong potential for bio-
medical applications, a deeper understanding of their interaction with cells is required for more efficient 
design of drug delivery systems. Moreover, whereas a wide range of studies have focused on the study of 
nanoparticles behavior in contact with cells, less is known about larger particles.
In the present study we compared the response of normal and tumoral breast epithelial cell lines to 
3 μ m microparticles with different surface properties. First, polystyrene microparticles were covalently 
conjugated to a fluorescently labelled secondary antibody. Then, the cationic polymer PEI at two different 
molecular weights was used to coat microparticles in order to 1) further modify their surface properties 
and, 2) evaluate how this could impact on their interaction with cells. Although PEI has been successfully 
used for gene delivery and/or functionalization of micro- and nanoparticles36–39, it has been proved to 
yield cytotoxic effects, depending on its form (linear or branched) and molecular weight40.
Thus, the first step in this work was to assess the cytotoxicity of free PEI-25 k and PEI-750K at a 
0.05 mM concentration. Given that PEI at that concentration did not trigger cytotoxic effects in either 
MCF-10A or SKBR-3 cells, microparticles were coated with PEI-25 k and PEI-750 K (0.05 mM). PEI coat-
ing clearly changed the surface of microparticles from negatively to positively charged. This change was 
significantly higher for PEI-750 K than for PEI-25 K, almost certainly due to the former having a higher 
molecular weight and a higher number of protonable amine groups than the latter.
To evaluate the surface charge effect of the PEI coating of microparticles on cellular uptake, flow 
cytometry was used to determine the internalization efficiency. Results showed that microparticle inter-
nalization was dependent on surface charge in both cell lines, as it has been previously described by 
other authors17,20,41. However, although it has been widely reported that positively charged microparticles 
are preferentially uptaken by cells, we observed that MCF-10A cells were more able to internalize nega-
tively charged non-coated microparticles than their PEI-coated counterparts. In contrast, in SKBR-3 cells 
the uptake increased with positively charged microparticles (PEI-coated), being nearly depreciable for 
non-coated ones (negatively charged). In fact, it has been reported that MCF-10A cells can internalize 
both positively18 and negatively26 charged nanoparticles and the same seems to apply to microparticles. 
Taken together, our results indicate that surface charge clearly determines microparticle uptake by cells. 
However, the uptake can be either enhanced or inhibited, depending on the cell type, which suggests 
that targeting to certain cell types can benefit from the microparticle surface charge. Thus, to identify the 
behavior of a specific cell line in front a specific particle is very important when designing new particles 
for drug delivery. Our results indicate that two human cell lines, both coming from the mammary epi-
thelia showed completely different uptake capability depending on their tumorigenic or non-tumorigenic 
nature.
The presence of serum in the culture medium is also critical for microparticle internalization, as a pro-
tein corona can form around micro/nano particles, modifying their surface42. In this regard, it is shown 
that the presence of serum had an inhibitory internalization effect on both cell lines and for all types of 
microparticles, except for internalization of non-coated microparticles by SKBR-3 cells and PEI-750 K 
coated microparticles by MCF-10A This finding highlights the impact of cell type on microparticle-cell 
interactions, and is in agreement with Yan et al. (2013), who observed a differential impact of protein 
corona in THP-1 monocytic cells and macrophages43.
In order to further investigate whether the mechanism of internalization was also dependent on 
the cell line and surface properties of microparticles, two endocytosis inhibitors, CD and Dyn, were 
used. CD has been reported to mainly inhibit macropinocytosis, whereas Dyn causes inhibition of 
dynamin-dependent endocytosis44, i.e. clathrin- and caveolin-mediated endocytosis. In the case of the 
SKBR-3 line, microparticle internalization was inhibited almost completely by CD but not by Dyn, both 
for non-coated and PEI-coated microparticles, indicating that in these cells microparticle internalization 
occurs by macropinocytosis rather than by dynamin-dependent mechanisms. It has been reported that 
SKBR-3 cells internalize their overexpressed ErbB2 receptors in a clathrin- and caveolin- independent 
endocytic pathway45. What is more, SKBR-3 cells lack caveolae, and ErbB2 internalization is sensitive to 
the depletion of cholesterol, which is necessary for most of the clathrin-independent pathways46. In addi-
tion, an association between macropinocytosis and tumor progression/metastasis has been reported47. 
Altogether, these studies could explain why SKBR-3 cells use the macropinocytosis pathway to internalize 
all types of microparticles, regardless of their surface properties.
By contrast, in MCF-10A cells, both CD and Dyn inhibited negatively charged microparticle uptake, 
suggesting that both macropinocitosis and dynamin-dependent endocytosis were involved. On the other 
hand, internalization of PEI-coated microparticles by MCF-10A cells was not affected by either CD or 
Dyn, suggesting that positively charged microparticles are internalized through alternative mechanisms 
in these cells. In addition, a higher percentage of PEI-750 K microparticles were internalized in the pres-
ence of Dyn than in its absence. This fact could be attributed to a compensatory effect, as it has been 
previously described that clathrin and caveolae dependent endocytosis inhibition can cause stimulation 
of macropinocytosis of positively charged nanoparticles22. However, further studies are needed to better 
understand this particular result. Taken together, all these findings suggest that both the surface charge 
and the cell type have a strong impact not only on the uptake efficiency, but also on the mechanism of 
microparticle internalization (Fig. 7).
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Finally, we assessed the intracellular location of microparticles in order to evaluate whether surface 
charge or cell type could affect the intracellular fate of the microparticles. Results showed that in all cases 
microparticles were located inside the lysosomal compartment, regardless of their surface properties and 
cell type. This suggests that despite the fact that PEI proton-sponge effect allows the delivery of DNA and 
small nanoparticles to the cytosol48, it is not capable of releasing large microparticles into the cytosol. 
In this regard, future research should be focused on alternative approaches for the efficient delivery of 
desired microparticles or molecules into the cytosol.
In summary, we have demonstrated that normal and tumor cells use different endocytic pathways 
when internalizing different types of modified microparticles. The tumor cell line SKBR-3 internalizes, 
mainly, positively charged microparticles, using the macropinocytosis pathway. When this pathway is 
inhibited, internalization is interrupted. By contrast, the non-tumor cell line MCF-10A uses different 
pathways to predominantly internalize negative microparticles. It seems that there is not a predominant 
uptake mechanism, and that compensatory internalization pathways are used when one of the path-
ways is inhibited. Regardless of the cell line and microparticle surface, the fate of the microparticles is 
always the lysosome compartment, even in presence of PEI-750 K. Thus new strategies, as pH sensitive 
cargo-link or esterase sensitive cargo-link, among others, must be envisaged to allow the liberation of the 
cargo to the cytoplasm. Consequently, the design of microcarriers against specific tissues must be done 
taken into account i) the surface of the microparticle and ii) the characteristics of the target cell, i.e., the 
uptake pathway and the final fate.
Methods
Functionalization of microparticles. Carboxylated microparticles (Polybead® Carboxylate 
Microspheres 3 μ m; Polysciences, Inc, Warrington, PA) were functionalized with an Alexa Fluor® 
Figure 7. Scheme of the differential mechanisms of microparticle internalisation by SKBR-3 and MCF-
10A cells. SKBR-3 cells internalized all types of microparticles by macropinocytosis, as their internalization 
was only inhibited by Cytochalasin D (CD). By contrast, MCF-10A cells showed different mechanisms 
of internalization, depending on the microparticle type. Non-coated Alexa488-IgG microparticles could 
be taken up by both macropinocytosis and dynamin-dependent endocitosis, as their internalization was 
inhibited by both CD and Dynasore (Dyn). By contrast, the uptake of PEI-25 K and PEI-750 K coated 
microparticles was not affected by either CD or Dyn, indicating that they are taken up by alternative 
mechanisms.
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9Scientific RepoRts | 5:11371 | DOi: 10.1038/srep11371
488 conjugated goat anti-Rabbit IgG H&L antibody (Life Technologies, Carlsbad, CA) using the 
PolyLink Protein Coupling kit (Polysciences, Inc.), following the manufacturer’s instructions 
(Alexa488-IgG-microparticles, from now on).
PEI coating and characterization of microparticles. To coat Alexa488-IgG microparticles with 
PEI, 5 μ L of PEI-25 K or PEI-750 K (10 mM) were diluted in 135 μ l of NaCl. In parallel, 3 μ L of micropar-
ticle solution (3 × 106 microparticles) was diluted in 137 μ L of NaCl. Then, the PEI solution was added to 
the microparticle solution, mixed slowly and left at room temperature (RT) for 40 min in order to form 
the PEI-Alexa488-IgG-microparticles complexes. After incubation, 720 μ l of serum-free culture medium 
was added to the solution to obtain a final 0.05 mM concentration of PEI. Non-coated functionalized 
(Alexa488-IgG-microparticles) and non-functionalized (-COOH microparticles) microparticles, were 
treated in the same way, but without PEI addition. ζ -Potential of microparticles was measured using a 
Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). Images of microparticles were recorded using 
a Scanning Electron Microscope (Zeiss Merlin, Jena, Germany). Fluorescence intensity of microparticles 
was analyzed using a Becton Dickinson FACSCanto II flow cytometer (BD Biosciences, Franklin Lakes, 
NJ) equipped with BD Biosciences FACSDiva™ software, in order to quantitatively determine the dis-
persion state of microparticles.
Cell culture. Experiments were conducted with two different human mammary epithelial cell lines, 
a non-tumorigenic (MCF-10A) and a metastatic one (SKBR-3). The MCF-10A cell line (ATCC) was 
cultured in DMEM/F12 (Gibco, Paisley, United Kingdom) supplemented with 5% horse serum (Gibco), 
20 ng/ml epidermal growth factor (Gibco), 0.5 mg/ml hydrocortisone (Sigma-Aldrich, St Louis, MO, 
USA), 100 ng/ml cholera toxin (Sigma) and 10 μ g/ml insulin (Gibco). The SKBR-3 adenocarcinoma cell 
line (ATCC) was cultured in McCoy’s 5A modified medium (Gibco) supplemented with 10% fetal bovine 
serum (Gibco). Both cell lines were maintained at 37 °C and 5% CO2 (standard conditions).
Polyethylenimine cytotoxicity analysis. PEI with a molecular weight of 25 kDa (PEI-25K) and 
750 kDa (PEI-750K) were purchased from Sigma and a 10 mM stock solution was prepared as previously 
described48.
MCF-10A and SKBR-3 cells were seeded in 35 mm Petri dishes (Nalge Nunc Int, Roskilde, Denmark) 
at a density of 1.5 × 105 cells/dish. After 48 h, culture medium was replaced with serum-free culture 
medium containing 0.05 mM of PEI-25 K or PEI-750 K and cells were maintained in standard condi-
tions. Control cells were treated in the same way but in absence of PEI. After 4 h of incubation, the 
medium was replaced by fresh supplemented culture medium and the cells were incubated again for 
24 h. Finally, cells were harvested by trypsinization and cytotoxicity was evaluated using the “LIVE/
DEAD® Viability/Cytotoxicity Kit for mammalian cells” (Life Technologies, Carlsbad, CA), following the 
manufacturer’s instructions. Cells were analyzed under a Becton Dickinson FACSCanto II flow cytome-
ter (BD Biosciences, Franklin Lakes, NJ) equipped with BD Biosciences FACSDiva™ software. For each 
treatment, four independent experiments were performed, where 20.000 cells were analyzed.
Microparticle internalization. MCF-10A and SKBR-3 cells were seeded in 35 mm petri dishes at 
a density of 1.5 × 105 cells/dish. After 48 h, the medium was removed and cells were incubated with 
Alexa488-IgG-microparticles either non-coated, or coated with PEI-25 K or PEI-750 K at a 5:1 ratio 
(microparticle:cell), in serum-free medium for 4 h in standard conditions. Microparticle internalization 
was evaluated at 4 h, when cells were harvested by trypsinization and analyzed under a flow cytometer. 
In order to distinguish internalized microparticles from those attached to the cell membrane, 2 mg/
ml Trypan Blue (TB, Sigma) was used to quench the extracellular fluorescence13,21. Cells were analyzed 
under a Becton Dickinson FACSCanto II flow cytometer both prior and after TB addition. This method 
allowed obtaining integrated information about cell viability and microparticle internalization efficiency 
(% of cells with internalized microparticles). For each PEI treatment and time of incubation, three inde-
pendent experiments were performed analyzing 20.000 cells each.
Endocytosis inhibition. To elucidate the mechanism of microparticles internalization, two endo-
cytosis inhibitors were used: Cytochalasin D (CD; macropinocitosis inhibition) and Dynasore (Dyn; 
Dynamin-dependent endocytosis inhibition). MCF-10A and SKBR-3 cells were seeded in 35 mm petri 
dishes at a density of 1.5 × 105 cells/dish. At 48 h, prior to the addition of microparticles, cells were 
pre-incubated for 1 h with 10 μ g/ml CD (Sigma-Aldrich), or 80 μ g/ml Dyn (Sigma-Aldrich) in serum-free 
medium. After that, pre-incubation medium was removed and cells were exposed to non-coated 
Alexa488-IgG-microparticles, PEI-25 K or PEI-750 K coated Alexa488-IgG-microparticles at a 5:1 ratio 
(microparticle:cell) in presence of the endocytosis inhibitors (10 μ g/ml CD, or 80 μ g/ml Dyn) for 4 h. 
Finally, cells were recovered by trypsinization and analyzed under a Becton Dickinson FACSCanto II 
flow cytometer.
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In addition, the effect of serum on microparticle internalization was tested by incubating the micropar-
ticles (non-coated and PEI-coated) in culture medium containing serum. After 4 h of incubation, the cells 
were trypsinized and microparticle internalization was evaluated by flow cytometry.
Immunofluorescence detection of endosomal and lysosomal compartments. Cells were 
seeded on coverslips in 4-well culture dishes at a density of 30,000 cells/well. After 48 h, they were 
exposed to functionalized microparticles, either non-coated or coated with PEI-25 K or PEI-750 K, at a 
5:1 ratio (microparticle:cell) and incubated for 4 h. Then, cells were washed twice with PBS, fixed with 
4% paraformaldehyde/PBS (Sigma-Aldrich), permeabilized with 0.1% Triton X-100 (Sigma-Aldrich) in 
PBS, and blocked with 5% PBS-BSA (Sigma-Aldrich) for 40 min. Cells were incubated for 1 h at 37 °C 
with either mouse anti-EEA-1 monoclonal antibody (BD Biosciences, Franklin Lakes, NJ) or mouse 
anti-LAMP-1 polyclonal antibody (BD Biosciences), in order to label endosomal or lysosomal com-
partments, respectively. After that, cells were washed thrice with PBS and incubated at RT for 1 h with 
Cy5-conjugated chicken anti-mouse IgG antibody (Life technologies). Finally, cells were washed twice 
with PBS and incubated with Alexa 594-Conjugated Phalloidin (5 ug/ml, Life Technologies) and Hoechst 
33258 (0.5 ug/ml, Life Technologies) to stain actin and DNA, respectively, prior to their analysis under 
a Confocal Laser Scanning Microscope (CLSM, Olympus XT7). For each labelling, treatment, and time 
of incubation with microparticles, at least 20 cells were analyzed.
Statistical analyses. Statistical analyses were conducted using a statistical package (IBM SPSS® for 
Windows, version 20.0; SPSS Inc., Chicago, IL, USA). Data were first tested for normality (Shapiro-Wilk 
test) and homogeneity of variances (Levene test). When necessary, data (x) in percentages were 
arcsine-transformed (arcsine √x) to accomplish the parametric assumptions (i.e. normal distribution 
and variance homogeneity).
A series of separate general linear models (analysis of variance, ANOVA) were run to test the effects 
of coated and non-coated microparticles and/or PEI concentrations on ζ-potential, cell viability and 
percentage of internalization. Briefly, the effects of PEI treatments on SKBR-3 and MCF-10A viability 
and internalization were determined through a two-way ANOVA (factors: PEI treatment and cell line, 
SKBR-3 and MCF-10A; variables: % cell viability or % internalization), followed by a post-hoc Sidak 
test, whereas ζ-Potential of carboxylated microparticles non functionalized (-COOH), Alexa 488-IgG 
functionalized microparticles (488IgG), Alexa488-IgG-microparticles coated with PEI25K (PEI25K) or 
PEI750K (PEI750K) was compared by a one-way ANOVA followed by a post-hoc Sidak test. Finally, 
the effects on non-coated, PEI-25 kDa-, PEI750kDa-coated microparticles intake of incubation with or 
without serum, or with endocytosis inhibitors (CD or Dyn) were tested in MCF-10A and SKBR-3 cells 
through a three-way ANOVA (factors: medium composition, PEI treatment, and cell line; variable: % 
internalization), again followed by a post-hoc Sidak test.
In all cases, the level of significance was set at P < 0.05. Data are presented as mean ± standard error 
of the mean (SEM).
References
1. Carregal-Romero, S. et al. Multiplexed sensing and imaging with colloidal nano- and microparticles. Annu. Rev. Anal. Chem. 
(Palo Alto. Calif). 6, 53–81 (2013).
2. Cederquist, K. B., Dean, S. L. & Keating, C. D. Encoded anisotropic particles for multiplexed bioanalysis. Wiley Interdiscip. Rev. 
Nanomed. Nanobiotechnol. 2, 578–600 (2010).
3. Sen, T. & Bruce, I. J. Surface engineering of nanoparticles in suspension for particle based bio-sensing. Sci. Rep. 2, 564 (2012).
4. Anker, J. N. et al. Biosensing with plasmonic nanosensors. Nat. Mater. 7, 442–53 (2008).
5. Yu, M. K., Park, J. & Jon, S. Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2, 
3–44 (2012).
6. Sanna, V., Pala, N. & Sechi, M. Targeted therapy using nanotechnology: focus on cancer. Int. J. Nanomedicine 9, 467–483 (2014).
7. Gu, F. X. et al. Targeted nanoparticles for cancer therapy. Nano Today 2, 14–21 (2007).
8. Jain, N. K., Mishra, V. & Mehra, N. K. Targeted drug delivery to macrophages. Expert Opin. Drug Deliv. 10, 353–67 (2013).
9. Caldorera-Moore, M. & Peppas, N. a. Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical 
systems. Adv. Drug Deliv. Rev. 61, 1391–401 (2009).
10. Cai, Y., Chen, Y., Hong, X., Liu, Z. & Yuan, W. Porous microsphere and its applications. Int. J. Nanomedicine 8, 1111–20 (2013).
11. Mura, S., Nicolas, J. & Couvreur, P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12, 991–1003 (2013).
12. Zauner, W., Farrow, N. a. & Haines, a. M. In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell 
density. J. Control. Release 71, 39–51 (2001).
13. Rejman, J., Oberle, V., Zuhorn, I. S. & Hoekstra, D. Size-dependent internalization of particles via the pathways of clathrin- and 
caveolae-mediated endocytosis. Biochem. J. 377, 159–69 (2004).
14. Pacheco, P., White, D. & Sulchek, T. Effects of microparticle size and Fc density on macrophage phagocytosis. PLoS One 8, e60989 
(2013).
15. Shang, L., Nienhaus, K. & Nienhaus, G. U. Engineered nanoparticles interacting with cells: size matters. J. Nanobiotechnology 12, 
5 (2014).
16. Barua, S. et al. Particle shape enhances specificity of antibody-displaying nanoparticles. Proc. Natl. Acad. Sci. USA 110, 3270–5 
(2013).
17. Gratton, S. E. a. et al. The effect of particle design on cellular internalization pathways. Proc. Natl. Acad. Sci. USA 105, 11613–8 
(2008).
18. Saha, K. et al. Surface functionality of nanoparticles determines cellular uptake mechanisms in mammalian cells. Small 9, 300–5 
(2013).
www.nature.com/scientificreports/
1 1Scientific RepoRts | 5:11371 | DOi: 10.1038/srep11371
19. Dausend, J. et al. Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. Macromol. Biosci. 8, 1135–43 
(2008).
20. Fröhlich, E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int. J. Nanomedicine 7, 
5577–91 (2012).
21. Thiele, L., Merkle, H. P. & Walter, E. Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and 
macrophages. Pharm. Res. 20, 221–8 (2003).
22. Harush-Frenkel, O., Debotton, N., Benita, S. & Altschuler, Y. Targeting of nanoparticles to the clathrin-mediated endocytic 
pathway. Biochem. Biophys. Res. Commun. 353, 26–32 (2007).
23. Patiño, T., Nogués, C., Ibáñez, E. & Barrios, L. Enhancing microparticle internalization by nonphagocytic cells through the use 
of noncovalently conjugated polyethyleneimine. Int. J. Nanomedicine 7, 5671–5682 (2012).
24. Boussif, O. et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. 
Natl. Acad. Sci. 92, 7297–7301 (1995).
25. Yu, J.-H., Quan, J.-S., Huang, J., Nah, J.-W. & Cho, C.-S. Degradable poly(amino ester) based on poly(ethylene glycol) 
dimethacrylate and polyethylenimine as a gene carrier: molecular weight of PEI affects transfection efficiency. J. Mater. Sci. Mater. 
Med. 20, 2501–10 (2009).
26. Xiao, Y. et al. Dynamics and mechanisms of quantum dot nanoparticle cellular uptake. J. Nanobiotechnology 8, 13 (2010).
27. Oliveira, S., Heukers, R., Sornkom, J., Kok, R. J. & van Bergen En Henegouwen, P. M. P. Targeting tumors with nanobodies for 
cancer imaging and therapy. J. Control. Release 172, 607–617 (2013).
28. Patino, T. et al. Multifunctional gold nanorods for selective plasmonic photothermal therapy in pancreatic cancer cells using 
ultra-short pulse near-infrared laser irradiation. Nanoscale 7, 5328–5337 (2015).
29. Conniot, J. et al. Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Front. Chem. 2, 105 
(2014).
30. Loureiro, J. A., Gomes, B., Coelho, M. A. N., do Carmo Pereira, M. & Rocha, S. Targeting nanoparticles across the blood-brain 
barrier with monoclonal antibodies. Nanomedicine (Lond). 9, 709–722 (2014).
31. Ferrati, S. et al. Inter-endothelial transport of microvectors using cellular shuttles and tunneling nanotubes. Small 8, 3151–60 
(2012).
32. Palankar, R. et al. Controlled intracellular release of peptides from microcapsules enhances antigen presentation on MHC class 
I molecules. Small 5, 2168–76 (2009).
33. Sukhorukov, G. B. et al. Multifunctionalized polymer microcapsules: novel tools for biological and pharmacological applications. 
Small 3, 944–955 (2007).
34. Delcea, M. et al. Multicompartmental Micro- and Nanocapsules: Hierarchy and Applications in Biosciences. Macromol. Biosci. 
10, 465–474 (2010).
35. Salonen, J. et al. Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs. J. Control. 
Release 108, 362–374 (2005).
36. Skandrani, N. et al. Lipid nanocapsules functionalized with polyethyleneimine for plasmid DNA and drug co-delivery and cell 
imaging. Nanoscale 6, 7379–90 (2014).
37. Kasturi, S. P., Sachaphibulkij, K. & Roy, K. Covalent conjugation of polyethyleneimine on biodegradable microparticles for 
delivery of plasmid DNA vaccines. Biomaterials 26, 6375–6385 (2005).
38. Ateh, D. D. et al. The intracellular uptake of CD95 modified paclitaxel-loaded poly(lactic-co-glycolic acid) microparticles. 
Biomaterials 32, 8538–47 (2011).
39. McBain, S. C., Yiu, H. H. P., El Haj, a. & Dobson, J. Polyethyleneimine functionalized iron oxide nanoparticles as agents for DNA 
delivery and transfection. J. Mater. Chem. 17, 2561 (2007).
40. Neu, M., Fischer, D. & Kissel, T. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its 
derivatives. J. Gene Med. 7, 992–1009 (2005).
41. Qiu, Y. et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31, 7606–19 (2010).
42. Wang, F. et al. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced 
by cationic nanoparticles until degraded in the lysosomes. Nanomedicine 9, 1159–68 (2013).
43. Yan, Y. et al. Differential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and 
macrophage cell lines. ACS Nano 7, 10960–70 (2013).
44. Macia, E. et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839–50 (2006).
45. Barr, D. J., Ostermeyer-Fay, A. G., Matundan, R. A. & Brown, D. A. Clathrin-independent endocytosis of ErbB2 in geldanamycin-
treated human breast cancer cells. J. Cell Sci. 121, 3155–3166 (2008).
46. Vaidyanath, A. et al. Enhanced internalization of ErbB2 in SK-BR-3 cells with multivalent forms of an artificial ligand. J. Cell. 
Mol. Med. 15, 2525–2538 (2011).
47. Lim, J. P. & Gleeson, P. A. Macropinocytosis : an endocytic pathway for internalising large gulps. Immunol. Cell Biol. 89, 836–843 
(2011).
48. Bousiff, O. et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine. 92, 
7297–7301 (1995).
Acknowledgements
This study was supported by grants from the Ministerio de Ciencia e Innovación (TEC2011-29140-C03), 
and the Generalitat de Catalunya (2014SGR-524) and the AGAUR FI-DGR 2013. The authors wish to 
thank the Unitat de Citometria de Flux and the Servei de Microscòpia at the Universitat Autònoma de 
Barcelona and Antonio Aranda for the help in drawing schematics.
Author Contributions
T.P., J.S., L.B, E.I. and C.N. designed the experiments. T.P. and J.S. performed the experiments. T.P. and 
L.B. performed the statistical analyses. C.N., L.B. and E.I. supervised the experiments. T.P. and C.N. 
wrote the manuscript. All authors critically revised the manuscript and approved the final version.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
www.nature.com/scientificreports/
1 2Scientific RepoRts | 5:11371 | DOi: 10.1038/srep11371
How to cite this article: Patiño, T. et al. Surface modification of microparticles causes differential 
uptake responses in normal and tumoral human breast epithelial cells. Sci. Rep. 5, 11371; doi: 10.1038/
srep11371 (2015).
This work is licensed under a Creative Commons Attribution 4.0 International License. The 
images or other third party material in this article are included in the article’s Creative Com-
mons license, unless indicated otherwise in the credit line; if the material is not included under the 
Creative Commons license, users will need to obtain permission from the license holder to reproduce 
the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
